Differing roles for urokinase and tissue-type plasminogen activator in collagen-induced arthritis.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  American Journal of Pathology

• Publication date

  2002-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0002-9440(10)64914-0PMID 11891190PMCID PMC1867189
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tissue-Type Plasminogen Activator Deficiency Exacerbates Arthritis1

  2001cited by this paper
• Urokinase-dependent plasminogen activation is required for efficient skeletal muscle regeneration in vivo.

  2001cited by this paper
• Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?

  2001cited by this paper
• Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease

  2001influential reference
• Amelioration of collagen-induced arthritis by thrombin inhibition.

  2001influential reference
• Tissue Plasminogen Activator–Mediated Fibrinolysis Protects against Axonal Degeneration and Demyelination after Sciatic Nerve Injury

  2000cited by this paper
• Enhanced expression of genes involved in coagulation and fibrinolysis in murine arthritis

  2000cited by this paper
• Collagen‐induced arthritis in C57BL/6 (H‐2b) mice: new insights into an important disease model of rheumatoid arthritis

  2000cited by this paper
• The colony‐stimulating factors and collagen‐induced arthritis: exacerbation of disease by M‐CSF and G‐CSF and requirement for endogenous M‐CSF

  2000cited by this paper
• IL-1αβ Blockade Prevents Cartilage and Bone Destruction in Murine Type II Collagen-Induced Arthritis, Whereas TNF-α Blockade Only Ameliorates Joint Inflammation

  1999cited by this paper
• The plasminogen activator system: biology and regulation

  1999influential reference
• Collagen-induced arthritis development requires alpha beta T cells but not gamma delta T cells: studies with T cell-deficient (TCR mutant) mice.

  1999cited by this paper
• IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation.

  1999cited by this paper
• Urokinase is required for T lymphocyte proliferation and activation in vitro.

  1999cited by this paper
• Collagen-induced arthritis development requires αβ T cells but not γδ T cells: studies with T cell-deficient (TCR mutant) mice

  1999cited by this paper
• B cell‐deficient mice do not develop type II collagen‐induced arthritis (CIA)

  1998cited by this paper
• Exacerbation of antigen-induced arthritis in urokinase-deficient mice.

  1998cited by this paper
• Protection from collagen-induced arthritis in granulocyte-macrophage colony-stimulating factor-deficient mice.

  1998cited by this paper
• Antiinflammatory activity of tissue plasminogen activator in the carrageenan rat footpad model.

  1997cited by this paper
• Plasminogen activation in synovial tissues: differences between normal, osteoarthritis, and rheumatoid arthritis joints

  1997cited by this paper
• Collagen-induced arthritis, an animal model of autoimmunity.

  1997cited by this paper
• Plasminogen and Plasminogen Activators Protect against Renal Injury in Crescentic Glomerulonephritis

  1997cited by this paper
• Attenuation of collagen-induced arthritis in 55-kDa TNF receptor type 1 (TNFR1)-IgG1-treated and TNFR1-deficient mice.

  1996cited by this paper
• Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen‐induced arthritis

  1996cited by this paper
• Endogenously produced urokinase amplifies tumor necrosis factor‐α secretion by THP‐1 mononuclear phagocytes

  1996cited by this paper
• Clinical improvement and radiological deterioration in rheumatoid arthritis: evidence that the pathogenesis of synovial inflammation and articular erosion may differ.

  1996cited by this paper
• Urokinase is required for the pulmonary inflammatory response to Cryptococcus neoformans. A murine transgenic model.

  1996cited by this paper
• Fibrin enhances the expression of IL-1 beta by human peripheral blood mononuclear cells. Implications in pulmonary inflammation.

  1995cited by this paper
• Physiological consequences of loss of plasminogen activator gene function in mice

  1994cited by this paper
• Plasminogen Activators and Their Inhibitors in Arthritic Disease

  1992influential reference
• Independent regulation of plasminogen activator inhibitor 2 and plasminogen activator inhibitor 1 in human synovial fibroblasts.

  1992cited by this paper
• Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis.

  1992cited by this paper
• Pathways of coagulation activation in situ in rheumatoid synovial tissue.

  1992cited by this paper
• Extravascular fibrin formation and dissolution in synovial tissue of patients with osteoarthritis and rheumatoid arthritis.

  1991cited by this paper
• Recombinant human interleukin-1 inhibits plasminogen activator inhibitor-1 (PAI-1) production by human articular cartilage and chondrocytes.

  1991cited by this paper
• Cell-associated plasminogen activation: regulation and physiological functions.

  1988cited by this paper
• Membrane and matrix localization of proteinases: a common theme in tumor cell invasion and angiogenesis.

  1988cited by this paper
• Type II collagen-induced murine arthritis. I. Induction and perpetuation of arthritis require synergy between humoral and cell-mediated immunity.

  1988cited by this paper
• Recombinant human interleukin-1 stimulates human articular cartilage to undergo resorption and human chondrocytes to produce both tissue- and urokinase-type plasminogen activator.

  1988cited by this paper
• Interleukin‐1β and interleukin‐1α stimulate the plasminogen activator activity and prostaglandin E2 levels of human synovial cells

  1987cited by this paper
• Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors

  1987cited by this paper
• Interleukin-1 beta and interleukin-1 alpha stimulate the plasminogen activator activity and prostaglandin E2 levels of human synovial cells.

  1987cited by this paper
• Intracellular localization of human monocyte associated interleukin 1 (IL 1) activity and release of biologically active IL 1 from monocytes by trypsin and plasmin.

  1986cited by this paper
• Genetic susceptibility to murine collagen II autoimmune arthritis. Proposed relationship to the IgG2 autoantibody subclass response, complement C5, major histocompatibility complex (MHC) and non-MHC loci

  1985cited by this paper
• [Rheumatoid arthritis].

  1983cited by this paper
• Stimulation of human synovial fibroblast plasminogen activator production by mononuclear cell supernatants.

  1981cited by this paper
• Stimulation of macrophage plasminogen activator activity by colony‐stimulating factors

  1980cited by this paper
• Immunocytology in arthritic joints.

  1967cited by this paper

• Pathogenic and Regulatory Roles of Fibrinolytic Factors in Autoimmune Diseases

  2025cites this paper
• Embelin ameliorated sepsis-induced disseminated intravascular coagulation intensities by simultaneously suppressing inflammation and thrombosis.

  2020cites this paper
• Identification and preclinical development of an anti-proteolytic uPA antibody for rheumatoid arthritis

  2020cites this paper
• Therapeutics targeting the fibrinolytic system

  2020cites this paper
• Role of plasminogen activator inhibitor - 1 (PAI-1) in regulating the pathogenesis of S. aureus arthritis via plasminogen pathway.

  2019cites this paper
• The Urokinase Plasminogen Activation System in Rheumatoid Arthritis: Pathophysiological Roles and Prospective Therapeutic Targets

  2019cites this paper
• The multifaceted role of fibrinogen in tissue injury and inflammation.

  2019cites this paper
• Antibody-Mediated Neutralization of uPA Proteolytic Function Reduces Disease Progression in Mouse Arthritis Models

  2018cites this paper
• Absence of functional compensation between coagulation factor VIII and plasminogen in double-knockout mice.

  2018cites this paper
• The Coagulation Factors Fibrinogen, Thrombin, and Factor XII in Inflammatory Disorders—A Systematic Review

  2018cites this paper
• Urokinase plasminogen activator and receptor promote collagen-induced arthritis through expression in hematopoietic cells.

  2017influential citation
• Impact of Autologous Bone Marrow-Derived Stem Cells on Degenerative Changes of Articulating Surfaces Associated With the Arthritic Temporomandibular Joint: An Experimental Study in Rabbits.

  2017cites this paper
• A New Explanation of Inflammation in Rheumatoid Arthritis Patients With Respect to Claudin-5, Matrix Metalloproteinase-9, and Neuroserpin.

  2016cites this paper
• GM‐CSF and uPA are required for Porphyromonas gingivalis‐induced alveolar bone loss in a mouse periodontitis model

  2015cites this paper
• Deficiency of hyaluronan synthase 1 (Has1) results in chronic joint inflammation and widespread intra-articular fibrosis in a murine model of knee joint cartilage damage.

  2015cites this paper
• Porphyromonas gingivalis-derived RgpA-Kgp Complex Activates the Macrophage Urokinase Plasminogen Activator System

  2015cites this paper
• Plasminogen Is a Joint‐Specific Positive or Negative Determinant of Arthritis Pathogenesis in Mice

  2014cites this paper
• Urokinase Plasminogen Activator Is a Central Regulator of Macrophage Three-Dimensional Invasion, Matrix Degradation, and Adhesion

  2014cites this paper
• Suppression of collagen-induced arthritis with a serine proteinase inhibitor (serpin) derived from myxoma virus.

  2014cites this paper
• Degradation, and Adhesion Three-Dimensional Invasion, Matrix Central Regulator of Macrophage Urokinase Plasminogen Activator Is a

  2014cites this paper
• The Plasminogen Activation System in Normal Tissue Remodeling

  2012cites this paper
• Fibrinolysis is down-regulated in mouse collagen-induced arthritis, but its normalization does not alleviate the course of disease

  2011influential citation
• The TGF-β superfamily cytokine, MIC-1/GDF15: A pleotrophic cytokine with roles in inflammation, cancer and metabolism

  2011cites this paper
• Regulation of systemic and local myeloid cell subpopulations by bone marrow cell-derived granulocyte-macrophage colony-stimulating factor in experimental inflammatory arthritis.

  2011cites this paper
• Transcriptomic analysis of peripheral blood monocytes and synovial macrophages in inflammatory arthritis

  2011cites this paper
• Urokinase-type plasminogen activator and arthritis progression: contrasting roles in systemic and monoarticular arthritis models

  2010influential citation
• Urokinase-type plasminogen activator and arthritis progression: role in systemic disease with immune complex involvement

  2010influential citation
• Role of hypoxia-inducible factor-1 alpha in the regulation of plasminogen activator activity in rat knee joint chondrocytes.

  2009cites this paper
• Plasminogen activator/plasmin system in arthritis and inflammation: friend or foe?

  2008cites this paper
• Emerging roles of serine proteinases in tissue turnover in arthritis.

  2008cites this paper
• Endogenous tissue-type plasminogen activator is protective during ascending urinary tract infection.

  2008cites this paper
• PLASMIN: A POTENT PRO-INFLAMMATORY FACTOR

  2008cites this paper
• A guide to murine fibrinolytic factor structure, function, assays, and genetic alterations

  2007cites this paper
• Fibrin(ogen) exacerbates inflammatory joint disease through a mechanism linked to the integrin alphaMbeta2 binding motif.

  2007cites this paper
• Epitopes of human fibrin recognized by the rheumatoid arthritis‐specific autoantibodies to citrullinated proteins

  2006cites this paper
• Anti‐TNF Effects on Destructive Fibroblasts Depend on Mechanical Stress

  2006cites this paper
• Endogenous Tissue-Type Plasminogen Activator Is Protective during Escherichia coli-Induced Abdominal Sepsis in Mice1

  2006cites this paper
• The effect of tissue type-plasminogen activator deletion and associated fibrin(ogen) deposition on macrophage localization in peritoneal inflammation

  2006cites this paper
• This information is current as-Induced Abdominal Sepsis in Mice coli Escherichia Activator Is Protective during Endogenous Tissue-Type Plasminogen

  2006cites this paper
• Clinical Correlation with the PA/Plasmin System in Septic Arthritis of the Knee

  2006cites this paper
• Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models.

  2006cites this paper
• Urokinase Inhibitor Design Based on Pharmacophore Model Derived from Diverse Classes of Inhibitors

  2006cites this paper
• CHAPTER 11 – Matrix Proteinases

  2006cites this paper
• Involvement of TNF-Like Weak Inducer of Apoptosis in the Pathogenesis of Collagen-Induced Arthritis1

  2006cites this paper
• Collagen-Induced Arthritis Apoptosis in the Pathogenesis of Involvement of TNF-Like Weak Inducer of Okumura Koyanagi

  2006cites this paper
• The plasminogen activator/plasmin system is essential for development of the joint inflammatory phase of collagen type II-induced arthritis.

  2005cites this paper
• Plasminogen activation/plasmin in rheumatoid arthritis: matrix degradation and more.

  2005cites this paper
• Regulatory polymorphisms in extracellular matrix protease genes and susceptibility to rheumatoid arthritis: a case-control study

  2005cites this paper
• Urokinase-type plasminogen activator receptor regulates leukocyte recruitment during experimental pneumococcal meningitis.

  2005cites this paper
• Tissue-type plasminogen activator modulates inflammatory responses and renal function in ischemia reperfusion injury.

  2005cites this paper
• MULTIFUNCTIONAL ROLES OF PLASMIN IN INFLAMMATION Studies of animal models on rheumatoid arthritis, multiple sclerosis, wound healing and infection

  2005influential citation
• ADMINISTRATION OF EXOGENOUS TISSUE PLASMINOGEN ACTIVATOR REDUCES OEDEMA IN MICE LACKING THE TISSUE PLASMINOGEN ACTIVATOR GENE

  2004cites this paper
• Novel aspects and new roles for the serine protease plasmin

  2004cites this paper
• Identification of novel binding interactions in the development of potent, selective 2-naphthamidine inhibitors of urokinase. Synthesis, structural analysis, and SAR of N-phenyl amide 6-substitution.

  2004cites this paper
• Matrix degrading proteases in the ovary : expression and function

  2004cites this paper
• Regulation and interactions in the activation of cell-associated plasminogen

  2004cites this paper
• uPA and uPAR in fibrinolysis, immunity and pathology.

  2004cites this paper
• Urokinase-type plasminogen activator (uPA) and its receptor (uPAR): development of antagonists of uPA/uPAR interaction and their effects in vitro and in vivo.

  2003cites this paper
• Regulation of plasminogen activation

  2003cites this paper
• Regulation of Plasminogen Activation HELI

  2003cites this paper
• Plasminogen: Structure, Activation, and Regulation

  2003cites this paper
• Plasminogen-Directed Phenotypes in Mice

  2003cites this paper
• Evaluation of repair process of osteochondral defects in rabbit articular cartilage with an inhibitor of plasminogen activator (tranexamic acid)

  2003cites this paper
• Extravascular coagulation and the plasminogen activator/plasmin system in rheumatoid arthritis.

  2002cites this paper